Market Overview:
The global HLA testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for HLA testing in medical diagnostics, research laboratories & academic institutes, and commercial service segments. Additionally, technological advancements in HLA testing are also contributing to the growth of this market. However, lack of awareness about HLA typing among end users is restraining the growth of this market. On the basis of type, reagents testing segment is expected to account for a larger share than instruments testing segment during the forecast period.
Product Definition:
HLA testing is a blood test that is used to determine a person's human leukocyte antigen (HLA) type. The HLA system is responsible for the body's immune response. This test can be used to help diagnose autoimmune diseases and organ rejection.
Reagents Testing:
Reagents testing is a technique used for detecting the presence of a disease-causing microorganism in samples of blood, tissue or fluid. Reagents are substances that enable specific and accurate detection of an infectious agent.
Instruments Testing:
Instruments testing is a process of evaluating the quality and effectiveness of medical devices used in healthcare facilities. It includes various tests such as microbiology, sterility, pyrogen & endotoxin testing, and chemical analysis among others. The most commonly used instruments are clinical laboratory equipment like reagent strips/assay kits/microplates along with biopsy devices & instruments.
Application Insights:
Medical diagnostic application segment to emerge as the fastest-growing segment over the forecast period owing to an increase in demand for rapid and accurate diagnosis. The introduction of next-generation sequencing (NGS) techniques has led to a considerable rise in research activities pertaining to HLA typing. NGS involves the use of molecular probes that are composed of DNA or RNA components that specifically hybridize with proteins expressed on human cells. These molecular probes are used for detecting and characterizing different genetic elements, such as transposons, viruses, bacteria, and cellular parasites within human genomic DNA samples.
HLA typing is increasingly being adopted by researchers working in various medical fields such as infectious diseases, immunology & allergy clinics, transplantation immunity clinics along with other laboratories & academic institutes engaged in basic or applied biomedical research related studies on humans.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of commercial entities, such as Quidel Corporation; Quest Diagnostics, Inc.; and Abbott Laboratories. These companies are engaged in HLA testing reagents production and distribution as well as through their own diagnostic centers. In addition, these players offer various research-based services for HLA typing along with its associated disorders across North America region.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing prevalence of chronic diseases coupled with rising disposable income levels among people in this region will drive demand for medical tests related to human leukocyte antigen (HLA) genotyping services over next eight years from 2018 to 2030 (USD X Million).
Growth Factors:
- Increasing incidence of autoimmune diseases: The global prevalence of autoimmune diseases is increasing at a significant rate. This is primarily attributed to the changing lifestyle and environmental factors. The HLA testing market is expected to benefit from this trend as it helps in early diagnosis and treatment of these diseases.
- Growing demand for personalized medicine: There is a growing demand for personalized medicines across the globe due to the increasing incidence of complex and rare diseases. HLA testing helps in identification of patients who are likely to respond favorably to a particular drug therapy, thus helping in better patient management.
- Technological advancements: The technological advancements in molecular biology are aiding the development of novel diagnostic techniques for HLA typing, which is expected to boost the growth prospects of this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
HLA Testing Market Research Report
By Type
Reagents Testing, Instruments Testing
By Application
Medical Diagnostic, Research Laboratories & Academic Institutes, Commercial Service
By Companies
Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson, Hologic, GenDx, Biofortuna
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global HLA Testing Market Report Segments:
The global HLA Testing market is segmented on the basis of:
Types
Reagents Testing, Instruments Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Diagnostic, Research Laboratories & Academic Institutes, Commercial Service
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- F. Hoffman-La Roche
- Bio-Rad Laboratories
- QIAGEN N.V.
- Illumina
- Immucor
- CareDx
- Becton Dickinson
- Hologic
- GenDx
- Biofortuna
Highlights of The HLA Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagents Testing
- Instruments Testing
- By Application:
- Medical Diagnostic
- Research Laboratories & Academic Institutes
- Commercial Service
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HLA Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HLA testing is a process used to identify the specific HLA types that are present in an individual. This information can be used to determine the potential compatibility of certain medications with that person.
Some of the key players operating in the hla testing market are Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson, Hologic, GenDx, Biofortuna.
The hla testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HLA Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HLA Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HLA Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HLA Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HLA Testing Market Size & Forecast, 2018-2028
4.5.1 HLA Testing Market Size and Y-o-Y Growth
4.5.2 HLA Testing Market Absolute $ Opportunity
Chapter 5 Global HLA Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 HLA Testing Market Size Forecast by Type
5.2.1 Reagents Testing
5.2.2 Instruments Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global HLA Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 HLA Testing Market Size Forecast by Applications
6.2.1 Medical Diagnostic
6.2.2 Research Laboratories & Academic Institutes
6.2.3 Commercial Service
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HLA Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HLA Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America HLA Testing Analysis and Forecast
9.1 Introduction
9.2 North America HLA Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America HLA Testing Market Size Forecast by Type
9.6.1 Reagents Testing
9.6.2 Instruments Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America HLA Testing Market Size Forecast by Applications
9.10.1 Medical Diagnostic
9.10.2 Research Laboratories & Academic Institutes
9.10.3 Commercial Service
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe HLA Testing Analysis and Forecast
10.1 Introduction
10.2 Europe HLA Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe HLA Testing Market Size Forecast by Type
10.6.1 Reagents Testing
10.6.2 Instruments Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe HLA Testing Market Size Forecast by Applications
10.10.1 Medical Diagnostic
10.10.2 Research Laboratories & Academic Institutes
10.10.3 Commercial Service
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific HLA Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific HLA Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific HLA Testing Market Size Forecast by Type
11.6.1 Reagents Testing
11.6.2 Instruments Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific HLA Testing Market Size Forecast by Applications
11.10.1 Medical Diagnostic
11.10.2 Research Laboratories & Academic Institutes
11.10.3 Commercial Service
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America HLA Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America HLA Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America HLA Testing Market Size Forecast by Type
12.6.1 Reagents Testing
12.6.2 Instruments Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America HLA Testing Market Size Forecast by Applications
12.10.1 Medical Diagnostic
12.10.2 Research Laboratories & Academic Institutes
12.10.3 Commercial Service
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) HLA Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) HLA Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) HLA Testing Market Size Forecast by Type
13.6.1 Reagents Testing
13.6.2 Instruments Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) HLA Testing Market Size Forecast by Applications
13.10.1 Medical Diagnostic
13.10.2 Research Laboratories & Academic Institutes
13.10.3 Commercial Service
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HLA Testing Market: Competitive Dashboard
14.2 Global HLA Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 F. Hoffman-La Roche
14.3.3 Bio-Rad Laboratories
14.3.4 QIAGEN N.V.
14.3.5 Illumina
14.3.6 Immucor
14.3.7 CareDx
14.3.8 Becton Dickinson
14.3.9 Hologic
14.3.10 GenDx
14.3.11 Biofortuna
